Related Experiment Video
Updated: May 4, 2026
14:18
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
2.2K
Statins stabilize the renal function of IgA nephropathy.
Takahito Moriyama1, Yasuko Oshima, Kayu Tanaka
1Department of Medicine, Kidney Center, Tokyo Women's Medical University , Tokyo , Japan.
Renal Failure
|December 18, 2013
Summary
Statins may stabilize renal function in IgA nephropathy (IgAN) patients. This study found improved kidney function after one year of statin therapy, independent of proteinuria reduction.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pharmacology
Background:
- The renoprotective effects of statins are recognized, but their impact on IgA nephropathy (IgAN) remains unclear.
- IgA nephropathy is a common glomerular disease with potential for progressive kidney damage.
Purpose of the Study:
- To investigate the effect of statin therapy on renal function and proteinuria in patients with IgA nephropathy.
- To assess changes in lipid metabolism and renal parameters after one year of statin treatment.
Main Methods:
- A cohort of 24 IgAN patients initiating statin therapy was observed.
- Clinical data, including renal function and lipid profiles, were compared one year before and after statin treatment.
- Patients receiving steroids or immunosuppressants were excluded.
Main Results:
- Statin therapy significantly improved lipid control in IgAN patients.
- While proteinuria did not significantly decrease, renal function showed improvement, with estimated glomerular filtration rate (eGFR) increasing by 2.4% (p=0.0098).
- Mean eGFR changed from a 5.9% decrease to a 2.4% increase post-treatment.
Conclusions:
- Statins appear to stabilize renal function in IgA nephropathy patients.
- The renoprotective effect of statins in IgAN may be independent of their impact on proteinuria.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.9K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.9K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
01:28Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:26Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409